These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
339 related items for PubMed ID: 28526572
1. Comprehensive evaluation of immunomodulation by moderate hypoxia in S. agalactiae vaccinated Nile tilapia. Gallage S, Katagiri T, Endo M, Maita M. Fish Shellfish Immunol; 2017 Jul; 66():445-454. PubMed ID: 28526572 [Abstract] [Full Text] [Related]
2. The effect of intermittent hypoxia under different temperature on the immunomodulation in Streptococcus agalactiae vaccinated Nile tilapia (Oreochromis niloticus). Wang J, Lu DQ, Jiang B, Luo HL, Lu GL, Li AX. Fish Shellfish Immunol; 2018 Aug; 79():181-192. PubMed ID: 29684601 [Abstract] [Full Text] [Related]
3. Vaccine-induced antibody level as the parameter of the influence of environmental salinity on vaccine efficacy in Nile tilapia. Wang J, He RZ, Lu GL, Luo HL, Lu DQ, Li AX. Fish Shellfish Immunol; 2018 Nov; 82():522-530. PubMed ID: 30118846 [Abstract] [Full Text] [Related]
4. Cross-immunity in Nile tilapia vaccinated with Streptococcus agalactiae and Streptococcus iniae vaccines. Wang Q, Fu T, Li X, Luo Q, Huang J, Sun Y, Wang X. Fish Shellfish Immunol; 2020 Feb; 97():382-389. PubMed ID: 31841691 [Abstract] [Full Text] [Related]
5. Passive immunization of Nile tilapia (Oreochromis niloticus) provides significant protection against Streptococcus agalactiae. Pasnik DJ, Evans JJ, Klesius PH. Fish Shellfish Immunol; 2006 Oct; 21(4):365-71. PubMed ID: 16531069 [Abstract] [Full Text] [Related]
9. Development of live attenuated Streptococcus agalactiae as potential vaccines by selecting for resistance to sparfloxacin. Pridgeon JW, Klesius PH. Vaccine; 2013 May 31; 31(24):2705-12. PubMed ID: 23583891 [Abstract] [Full Text] [Related]
10. Development of attenuated erythromycin-resistant Streptococcus agalactiae vaccine for tilapia (Oreochromis niloticus) culture. Liu L, Lu DQ, Xu J, Luo HL, Li AX. J Fish Dis; 2019 May 31; 42(5):693-701. PubMed ID: 30893488 [Abstract] [Full Text] [Related]
11. Development of live attenuated Streptococcus agalactiae vaccine for tilapia via continuous passage in vitro. Li LP, Wang R, Liang WW, Huang T, Huang Y, Luo FG, Lei AY, Chen M, Gan X. Fish Shellfish Immunol; 2015 Aug 31; 45(2):955-63. PubMed ID: 26087276 [Abstract] [Full Text] [Related]
12. Efficacy of Streptococcus agalactiae (group B) vaccine in tilapia (Oreochromis niloticus) by intraperitoneal and bath immersion administration. Evans JJ, Klesius PH, Shoemaker CA. Vaccine; 2004 Sep 09; 22(27-28):3769-73. PubMed ID: 15315858 [Abstract] [Full Text] [Related]
17. Immune response and protective efficacy of two new adjuvants, Montanide™ ISA 763B VG and Montanide™ GEL02, administered with a Streptococcus agalactiae ghost vaccine in Nile tilapia (Oreochromis niloticus). Wangkaghart E, Deville S, Wang B, Srisapoome P, Wang T, Secombes CJ. Fish Shellfish Immunol; 2021 Sep 09; 116():19-29. PubMed ID: 34153428 [Abstract] [Full Text] [Related]
20. Generation of a novel Streptococcus agalactiae ghost vaccine and examination of its immunogenicity against virulent challenge in tilapia. Wang Q, Wang X, Wang X, Feng R, Luo Q, Huang J. Fish Shellfish Immunol; 2018 Oct 09; 81():49-56. PubMed ID: 29969706 [Abstract] [Full Text] [Related] Page: [Next] [New Search]